Rene Sindlev - 20 Feb 2024 Form 4 Insider Report for RENOVARO INC. (RENB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Feb 2024, 16:35:47 UTC
Prior SEC filing
15 Feb 2024
Next SEC filing
27 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rene Sindlev

Key filing fact

Rene Sindlev filed Form 4 for RENOVARO INC. (RENB) on 22 Feb 2024.

Key facts

  • This page summarizes Rene Sindlev's Form 4 filing for RENOVARO INC. (RENB).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 22 Feb 2024, 16:35.

Change

  • Previous filing in this sequence was filed on 15 Feb 2024.
  • Current net transaction value: +$250,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RENB transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$250,000
Shares
+471,699
Change %
+3.6%
Price
$0.5300
Shares after
13,605,297
Date
20 Feb 2024
Ownership
By RS Bio ApS

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RENB transaction Derivative

Warrant (Right to Buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-471,699
Change %
-50%
Price
$0.000000
Shares after
471,698
Date
20 Feb 2024
Ownership
By RS Bio ApS
Underlying class
Common Stock
Underlying amount
471,699
Exercise price
$0.5300
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .